Rhinosporidiosis is a chronic granulomatous infection of the mucous membranes that usually manifests as vascular friable polyps that arise from the nasal mucosa or external structures of the eye.
Initially described by Seeber in 1900 in an individual from Argentina,  rhinosporidiosis is endemic in India, Sri Lanka, South America, and Africa. [2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12] Cases from the United States and Southeast Asia, as well as scattered occurrences throughout the world, have also been reported. Most cases of rhinosporidiosis occur in persons from or residing in the Indian subcontinent or Sri Lanka. In addition to humans, disease has been noted in cats, cattle, dogs, ducks, goats, horses, mules, parrots, and swan. 
The etiologic agent, Rhinosporidium seeberi, has never been successfully propagated in vitro. Initially thought to be a parasite, for more than 50 years R seeberi had been considered a water mold.  Molecular biological techniques have more recently demonstrated this organism to be an aquatic protistan parasite, and it has been placed into a new class, the Mesomycetozoea, along with organisms that cause similar infections in amphibians and fish. [15, 16, 17] This reclassification is not without controversy, as other researchers have presented data that R seeberi is a cyanobacterium, further demonstrating the difficulties that arise when working with pathogens that cannot be maintained in the laboratory setting. [18, 19] Other molecular work has demonstrated evidence that R seeberi may have host-specific strains (eg, human vs dog versus swan). 
Rhinosporidiosis is an infection that is typically limited to the mucosal epithelium. Infection usually results from a local traumatic inoculation with the organism. The disease progresses with the local replication of R seeberi and associated hyperplastic growth of host tissue and a localized immune response.
Infection of the nose and nasopharynx is observed in 70% of persons with rhinosporidiosis; infection of the palpebral conjunctivae or associated structures (including the lacrimal apparatus) is observed in 15%. 
Other structures of the mouth, upper airway, and eye may be sites of disease. Disease of the skin, ear, larynx, trachea, bronchi, genitals, and rectum has also been described.  Genital disease has been described in the vagina, penile urethra or meatus, and scrotum.  Dissemination with cutaneous and multisite disease is also reported, but this is much less common. Isolated cases of dissemination involving deep organs have been rarely reported. [24, 25]
Cases in the United States are rare but are more common in Texas and the Southeast.
Rhinosporidiosis usually affects persons in or from southern India and Sri Lanka. Cases have been reported worldwide, with an increased incidence in South America and Africa.
Rhinosporidiosis can cause prolonged painless disease with limited morbidity. Disease of up to 30 years' duration has been reported. Secondary bacterial infection can cause morbidity. Death has been reported in only the few rare reports of disseminated disease.
Rhinosporidiosis has no known racial predilection.
Men are affected more commonly than women, with a male-to-female ratio of 4:1.
The disease most commonly occurs in children and in individuals aged 15-40 years.